Poster Abstract Session:
64. Microbiome and Beyond
Thursday, October 4, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Adult ID, Investigative ID


Presentations:
614
Modeling Changes in Gastrointestinal and Respiratory Tract Bacterial Community Diversity Attributable to Common Antibiotic Exposures During Long-Term Acute Care
Erik Clarke, Ph.D.; Emily Reesey, MS; Ebbing Lautenbach, MD, MPH, MSCE, FIDSA, FSHEA; Magda Wernovsky, BA; Brendan J. Kelly, MD, MS
Posters
  • MIRA_IDWeek2018.pdf (755.3 kB)
  • 615
    Can we restore the Lung Microbiome with Fecal Microbiota Transplant (FMT)?
    Roberto Mendez, PhD; Santanu Banerjee, PhD; Octavio Martinez, PhD; Armando Perez-Cardona, BS; Lilian M. Abbo, MD
    616
    Vancomycin is Frequently Administered to Hematopoietic Cell Transplant Recipients Without a Provider Documented Indication and Correlates with Microbiome Disruption and Adverse Events.
    Jonathan Golob, MD PhD; Erica Stohs, MD; Ania Sweet, PharmD; Steven Pergam, MD MPH; Michael Boeckh, MD PhD; David Fredricks, MD; Catherine Liu, MD
    617
    Characterization and development of the infant gut virome: A STORK study
    Andrea Granados, PhD; Susanna K. Tan, MD; Jerome Bouquet, PhD; Charles Y. Chiu, M.D., Ph.D.; Julie Parsonnet, MD, FIDSA; Lauri Green, BSc
    618
    DO CLINICAL FACTORS AFFECT MICROBIAL ENGRAFTMENT AFTER FECAL MICROBIOTA TRANSPLANTATION IN RECURRENT CLOSTRIDIUM DIFFICILE INFECTION?
    Shrish Budree, MD; Majdi Osman, MD MPH; Pratik Panchal, MD; Edina Shu, B.S.; Madeline Carrellas, B.A.; Zain Kassam, MD MPH; Jessica Allegretti, MD, MPH
    619
    Intestinal Microbiome Changes Associated with Immune Status and Clostridium difficile Colonization in Hospitalized Children
    Sindhu Mohandas, MD; Vijaya L Soma, MD; Tresa Ambooken, MD; David Goldman, MD; Dong-Ninh Tran, PhD; George Weinstock, PhD; Erica Sodergren, PhD; Betsy C. Herold, MD, FIDSA, FPIDS
    Posters
  • ID week poster 9_26_2018.pdf (499.1 kB)
  • 620
    Oral Beta-Lactamase Therapies Prevent Microbiome Damage and Attenuate Antibiotic Resistance from IV and Oral Antibiotics in Large Animal Models of Antibiotic-Mediated Gut Dysbiosis
    Sheila Connelly, PhD; Christian Furlan-Freguia, PhD; Brian Fanelli, BS; Nur A. Hasan, PhD; Rita R. Colwell, PhD; Michael Kaleko, MD, PhD
    621
    Treatment of recurrent Clostridium difficile infection with SER-109 increases the concentration of secondary bile acids in a dose dependent manner.
    Matthew Henn, Ph.D.; Christopher Ford, PhD; Edward O'Brien, Ph.D.; Jennifer Wortman, Ph.D.; Liyang Diao, Ph.D.; Christopher Desjardins, PhD; Amelia Tomlinson, PhD; Kevin Litcofsky, Ph.D.; Mark Wilcox, MD; Anthony Buckley, PhD; Patricia Bernardo, Sc.D.; Barbara McGovern, MD; John G. Aunins, Ph.D.; David N. Cook, Ph.D.; Michele Trucksis, Ph.D., M.D.
    622
    Increased IgA coating of gut microbes after administration of killed, whole-cell oral cholera vaccine
    Ana Weil, MD, MPH; Taufiq Bhuiyan, PhD; Meti Debela, BS; Fahima Chowdhury, MBBS; Ashraful Khan, MBBS; Regina LaRocque, MD, MPH, FIDSA; Edward Ryan, MD; Stephen B. Calderwood, MD, FIDSA; Firdausi Qadri, PhD; Jason Harris, MD, MPH, FIDSA
    Posters
  • IDWeekposter_Weil.final.pdf (1.4 MB)
  • 623
    Dynamic nature of the gut resistome among infants in Singapore
    Amanda Zain, MMed; Gaik Chin Yap, MSc; Rikky W. Purbojati, MSc; Daniela Isabel Moses, PhD; Lynette P.C. Shek, FRCPCH; Anne Goh, MMed; Hugo P. S. Van Bever, PhD; Oon Hoe Teoh, MMed; Jian Yi Soh, MMed; Biju Thomas, MD; Mahesh Babu Ramamurthy, MD; Daniel Y. T. Goh, MMed; Christophe Lay, PhD; Evelyn Loo Xiu Ling, PhD; Shu-E Soh, PhD; Fabian Yap, MMed; Kok Hian Tan, MRCOG; Yap-Seng Chong, PhD; Keith M. Godfrey, PhD; Peter D. Gluckman, MD; Stephan Schuster, PhD; Ritu Banerjee, MD, PhD; Bee Wah Lee, MBBS
    624
    Microbiota and Associations with Treatment Outcome in Fecal Microbiota Transplantation
    Tatiana Bogdanovich, MD PhD; Alison Morris, MD, MS; Adam Fitch, BS; Kelvin Li, MS, MBA; Rachel Nettles, BS; Nicolas Sluis-Cremer, PhD; Barbara Methe, PhD
    Posters
  • 624_IDWPOSTER original.pdf (1.1 MB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.